Dopamine partial agonists and prodopaminergic drugs for schizophrenia: Systematic review and meta-analysis of randomized controlled trials.
Neurosci Biobehav Rev
; 135: 104568, 2022 04.
Article
in En
| MEDLINE
| ID: mdl-35131396
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Schizophrenia
/
Antipsychotic Agents
Type of study:
Clinical_trials
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
Neurosci Biobehav Rev
Year:
2022
Document type:
Article
Country of publication:
United States